<DOC>
	<DOCNO>NCT00903604</DOCNO>
	<brief_summary>The purpose present research study investigate pharmacokinetics , well safety , tolerability pharmacodynamics different ascend dose regimen AP214 patient undergo cardiac surgery . AP214 , investigational drug , develop potentially prevent post-surgical kidney injury thoracic aortic aneurysm repair .</brief_summary>
	<brief_title>Pharmacokinetics AP214 Acetate Patients Undergoing Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<criteria>1 . Has sign trialspecific inform consent form . 2 . Patients ≥ 18 year old , male female , childbearing potential ( postmenopausal permanently sterilize , e.g . tubal ligation , hysterectomy , bilateral salpingectomy ) , regardless ethnicity . 3 . Patients undergo CABG , valve ( ) , CABG/valve ( ) and/or aortic root ascend aortic aneurysm repair surgery . 4 . Cleveland Clinic Renal Score ≥ 2 ( high average risk AKI ) . 5 . EF ≥ 30 % , evaluate within 2 month prior screen visit . 1 . Cardiac surgery perform `` pump '' without cardiopulmonary bypass . 2 . Circulatory arrest connection aortic root ascend aortic aneurysm repair surgery . 3 . Confirmed suspected endocarditis . 4 . Requiring reoperation one valves within 3 month follow original valve surgical procedure . 5 . Receiving Aprotinin trial , Screening Day 90 . 6 . Having undergone cardiovascular catheterization ≤ 48 hour prior schedule surgery . 7 . Active peptic ulcer disease gastritis . 8 . Hemoccult positive stool , hematological , bleeding , coagulation disorder . 9 . Receiving dopamine renal dos ( 24 mcg/kg/min ) , Screening Day surgery . 10 . SCreatinine great 2.1 mg/dl . 11 . Known suspected hypersensitivity investigational medicinal product . 12 . Known suspected hypersensitivity Ondansetron selective 5hydroxytryptamine 3 ( 5HT3 ) receptor antagonist . 13 . Current participation interventional clinical trial . 14 . Previously dose AP214 . 15 . Use investigational medicinal product within previous 6 month . 16 . Body weight 140 kg . 17 . History organ transplant . 18 . Women childbearing potential , pregnant , breastfeed . 19 . Current abuse alcohol substance , accord investigator 's medical judgment . 20 . Has mental incapacity language barrier preclude adequate understanding trial procedure . 21 . Is consider Investigator unsuitable participate trial reason , instance due significant serious underlie condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>coronary artery bypass grafting</keyword>
	<keyword>valve surgery</keyword>
	<keyword>aortic root ascend aortic aneurysm repair surgery</keyword>
	<keyword>Acute kidney injury</keyword>
</DOC>